Results
3042
Most Popular Stocks on the market
3042 companies
NUTEX Investments
Market Cap: Ft2.6b
Provides health preserving, health improving, dietary supplement, and cosmetic products in Hungary and internationally.
NUTEX
Ft16.40
7D
0%
1Y
-13.5%
Cambium Bio
Market Cap: AU$11.9m
A clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications.
CMB
AU$0.52
7D
3.0%
1Y
35.1%
RBC Bioscience
Market Cap: NT$236.2m
Researches, develops, manufactures, and sells reagents and devices for life science and molecular diagnosis in Europe, the United States, Asia, Taiwan, Africa, and Australia.
6848
NT$18.20
7D
1.4%
1Y
2.7%
Actavia Life Sciences
Market Cap: US$7.7m
A leukemia-focused biotechnology company, engages in developing therapeutics for the treatment of acute myeloid leukemia (AML) and other forms of leukemia and lymphoma.
RASP
US$0.01
7D
0%
1Y
n/a
N4 Pharma
Market Cap: UK£5.7m
A specialist pharmaceutical company, develops nanoparticle silica delivery systems to enhance the cellular delivery and potency of cancer treatments and vaccines in the United Kingdom.
N4P
UK£0.0069
7D
38.0%
1Y
25.5%
Welcure Drugs and Pharmaceuticals
Market Cap: ₹680.9m
Engages in trading of agriculture products in India.
524661
₹6.06
7D
-17.9%
1Y
-21.2%
Biofil Chemicals and Pharmaceuticals
Market Cap: ₹679.8m
Engages in manufacturing and trading of pharmaceuticals in India.
524396
₹41.77
7D
-3.6%
1Y
-48.3%
NuCana
Market Cap: US$7.6m
A clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer.
NCNA
US$4.01
7D
8.7%
1Y
-99.2%
Galmed Pharmaceuticals
Market Cap: US$7.6m
A biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases.
GLMD
US$1.40
7D
-4.1%
1Y
-80.3%
AIM ImmunoTech
Market Cap: US$7.6m
An immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States.
0A4Y
US$2.79
7D
7.8%
1Y
-89.9%
Y.B Urban Renewal - Residential Development
Market Cap: ₪25.3m
Engages in the cultivation and production of medical cannabis.
YBRD
₪6.15
7D
-6.1%
1Y
-62.1%
American Films
Market Cap: US$7.5m
Does not have significant operations.
AMFL
US$0.12
7D
18.4%
1Y
-24.9%
Entero Therapeutics
Market Cap: US$7.5m
A clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases.
ENTO
US$4.75
7D
-7.9%
1Y
360.7%
AFC Agro Biotech
Market Cap: ৳910.2m
Engages in the manufacture and sale of bio-pharmaceuticals and bio-chemical products in Bangladesh.
AFCAGRO
৳7.90
7D
1.3%
1Y
-17.7%
Concord Drugs
Market Cap: ₹662.0m
Engages in the manufacture and sale of pharmaceutical formulations in India.
538965
₹66.20
7D
-2.6%
1Y
77.6%
Aton
Market Cap: €6.4m
Operates as a bioscience company in France.
ALTAO
€0.0078
7D
2.6%
1Y
-44.3%
Spago Nanomedical
Market Cap: SEK 70.0m
A clinical phase nanomedicine company, engages in the development of nanomedicines for cancer diagnostics and treatment primarily in Sweden.
SPAGO
SEK 0.20
7D
-4.3%
1Y
-19.0%
Alzamend Neuro
Market Cap: US$7.4m
A clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.
ALZN
US$2.41
7D
0.4%
1Y
-84.9%
Ayala Pharmaceuticals
Market Cap: US$7.4m
A clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers.
ADXS
US$0.091
7D
77.9%
1Y
94.3%
Accretion Pharmaceuticals
Market Cap: ₹653.6m
Engages in the manufacturing and marketing of pharmaceutical products in India.
ACCPL
₹58.80
7D
-9.3%
1Y
n/a
Godavari Drugs
Market Cap: ₹651.5m
Manufactures and sells active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India.
530317
₹86.51
7D
1.2%
1Y
-30.0%
AcouSort
Market Cap: SEK 69.0m
A technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.
ACOU
SEK 3.26
7D
0.3%
1Y
-77.9%
Adial Pharmaceuticals
Market Cap: US$7.3m
A clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders.
ADIL
US$0.34
7D
-1.7%
1Y
-65.9%
Brainstorm Cell Therapeutics
Market Cap: US$7.3m
A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.
BCLI
US$0.71
7D
1.5%
1Y
-78.7%
Innovotech
Market Cap: CA$10.0m
Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.
IOT
CA$0.20
7D
-4.8%
1Y
48.1%
Cardio Diagnostics Holdings
Market Cap: US$7.2m
Develops and commercializes epigenetics-based clinical tests for cardiovascular disease.
CDIO
US$4.07
7D
2.0%
1Y
-38.1%
Christina Lake Cannabis
Market Cap: CA$9.9m
A license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada.
CLC
CA$0.04
7D
-11.1%
1Y
14.3%
Vista Pharmaceuticals
Market Cap: ₹630.3m
Manufactures and sells pharmaceutical, medical, and veterinary preparations in India and internationally.
524711
₹10.24
7D
7.8%
1Y
-25.3%
Percheron Therapeutics
Market Cap: AU$10.9m
Engages in the research and development of novel antisense pharmaceuticals for cancer and rare diseases in Australia.
PER
AU$0.01
7D
0%
1Y
-90.0%
Palisade Bio
Market Cap: US$7.0m
A clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases.
PALI
US$0.90
7D
49.7%
1Y
-73.2%
OLIPASS
Market Cap: ₩9.6b
A biotech company, focuses on developing therapeutic products in South Korea.
A244460
₩1,651.00
7D
0%
1Y
-70.0%
Pure Biologics
Market Cap: zł25.6m
A biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases.
PUR
zł6.28
7D
-4.6%
1Y
-68.9%
Silo Pharma
Market Cap: US$7.0m
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company.
SILO
US$0.77
7D
12.6%
1Y
-29.3%
Remedium Lifecare
Market Cap: ₹616.9m
A pharmaceutical company, trades and sells active pharmaceutical ingredients (API) and intermediates in India and internationally.
539561
₹1.53
7D
0.7%
1Y
-82.8%
Proteome Sciences
Market Cap: UK£5.2m
Provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally.
PRM
UK£0.018
7D
-42.3%
1Y
-41.7%
Soligenix
Market Cap: US$6.9m
A late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States.
SNGX
US$1.20
7D
-55.4%
1Y
-68.1%